Cytokinetics
CYTK
#2423
Rank
A$10.84 B
Marketcap
A$77.83
Share price
-3.35%
Change (1 day)
-18.68%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2023 (TTM): A-$8.57

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is A-$10.47. In 2022 the company made an earnings per share (EPS) of A-$6.16 a decrease over its 2021 EPS that were of A-$4.10.

EPS history for Cytokinetics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$8.5739.02%
2022A-$6.1650.18%
2021A-$4.1040.8%
2020A-$2.91-4.74%
2019A-$3.068.21%
2018A-$2.83-24.12%
2017A-$3.73-776.32%
2016A$0.55-139.18%
2015A-$1.41125.58%
2014A-$0.62-67.67%
2013A-$1.93-44.58%
2012A-$3.48-44.95%
2011A-$6.32-6.84%
2010A-$6.78-290.24%
2009A$3.57-135.96%
2008A-$9.9210.68%
2007A-$8.96-33.97%
2006A-$13.575.41%
2005A-$12.87-60.64%
2004A-$32.71-77.21%
2003A-$143.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
A$23.51-324.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A-$50.36 381.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$14.51-238.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A-$72.93 596.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A-$1.42-86.43%๐Ÿ‡บ๐Ÿ‡ธ USA